Author: BusinessWire

iStent inject Achieved 42% Reduction in Mean IOP to 14.6 mmHg and 82% Reduction in Mean Medications to 0.55 at…

NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic…

Chairman and CEO Kevin Hrusovsky to present at BIO and provide details about the HD-X launch and vision for continuing…

STAT will bring together health care and life science leaders from across the country in November 2019 to explore the…

DUBLIN–(BUSINESS WIRE)–The “Global Amyotrophic Lateral Sclerosis Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Amyotrophic…

DUBLIN–(BUSINESS WIRE)–The “Global Hyperlipidemia Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Hyperlipidemia Pipeline Highlights…

DUBLIN–(BUSINESS WIRE)–The “Global Lung Cancer Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. This report,…

DUBLIN–(BUSINESS WIRE)–The “Global Epilepsy Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. This report, Epilepsy…

PHILADELPHIA–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) released “Transforming Ideas into Advances: Best Practices in State and Regional Bioscience Economic Development…

DUBLIN–(BUSINESS WIRE)–The “Global Neuropathic Pain Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Neuropathic Pain…